Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PRE

Prenetics Global Limited

Apr 17 • 04:00PM ET

3.15

Dollar change -0.06
Percentage change -1.87	%

Healthcare • Diagnostics & Research • Hong Kong • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.85	Insider Own	37.19%	Shs Outstand	12.13M	Perf Week	-21.05%
Market Cap	38.21M	Forward P/E	-	EPS next Y	-0.74	Insider Trans	0.00%	Shs Float	7.62M	Perf Month	-30.92%
Income	-64.82M	PEG	-	EPS next Q	-1.02	Inst Own	10.34%	Short Float	0.17%	Perf Quarter	-27.75%
Sales	33.69M	P/S	1.13	EPS this Y	-42.18%	Inst Trans	-15.42%	Short Ratio	0.16	Perf Half Y	-51.14%
Book/sh	18.67	P/B	0.17	EPS next Y	79.39%	ROA	-19.70%	Short Interest	0.01M	Perf Year	-73.81%
Cash/sh	6.00	P/C	0.53	EPS next 5Y	-	ROE	-25.15%	52W Range	3.16 - 15.90	Perf YTD	-46.70%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-31.28%	52W High	-80.19%	Beta	-0.05
Dividend TTM	-	Quick Ratio	2.08	Sales past 5Y	-46.07%	Gross Margin	42.48%	52W Low	-0.32%	ATR (14)	0.36
Dividend Ex-Date	Nov 04, 2015	Current Ratio	2.16	EPS Y/Y TTM	87.07%	Oper. Margin	-159.69%	RSI (14)	31.88	Volatility	10.34% 10.01%
Employees	-	Debt/Eq	0.08	Sales Y/Y TTM	-81.66%	Profit Margin	-192.41%	Recom	1.00	Target Price	9.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-15980.81%	Payout	-	Rel Volume	0.98	Prev Close	3.21
Sales Surprise	-27.62%	EPS Surprise	89.34%	Sales Q/Q	-89.62%	Earnings	Apr 01 BMO	Avg Volume	78.65K	Price	3.15
SMA20	-20.45%	SMA50	-30.45%	SMA200	-51.82%	Trades		Volume	77,282	Change	-1.87%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-18-23	Initiated	Cantor Fitzgerald	Overweight	$7

Apr-01-24 01:53PM	PRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:30AM	Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-09-24 09:25AM	Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station (GlobeNewswire)
Nov-20-23 06:00AM	Prenetics Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-01-23 06:00AM	Prenetics Global Limited Announces Reverse Stock Split (GlobeNewswire)
07:10AM	Loading…
Sep-15-23 07:10AM	Prenetics Announces Second Quarter 2023 Financial Results (PR Newswire)
Aug-29-23 12:46AM	A World's First: The Miss Hong Kong Pageant 2023 Unveiled Contestants' CircleDNA Results Live on Television (PR Newswire)
Jun-30-23 08:00AM	Prenetics Global signs "transformational" $200mln deal to create cancer screening JV (News Direct) +5.65%
Jun-26-23 09:30AM	Prenetics Announces $200M JV with Prof. Dennis Lo for Multi-Cancer Early Detection Screening (Exec Edge)
Jun-25-23 08:45PM	Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture Insighta for Breakthrough Multi-Cancer Early Detection Screening (GlobeNewswire)
Jun-05-23 07:20AM	Prenetics Announces First Quarter 2023 Financial Results (PR Newswire) +7.97%
Mar-14-23 08:56AM	Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results (PR Newswire) -6.40%
Mar-02-23 07:00AM	Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology (PR Newswire)
Feb-02-23 04:01PM	Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-19-23 05:00AM	Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA (PR Newswire) -5.52%
10:00AM	Loading…
Jan-17-23 10:00AM	Sidoti's January Micro-Cap Conference (ACCESSWIRE) -13.56%
Jan-10-23 08:05AM	Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors (PR Newswire) +22.04%
Dec-16-22 06:27AM	Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology (GlobeNewswire) +17.10%
Nov-30-22 09:15AM	Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index (PR Newswire)
Nov-10-22 08:00AM	Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance (GlobeNewswire)
Sep-09-22 11:17AM	Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook (PR Newswire) +11.81%
Aug-12-22 09:34AM	The past year for Prenetics Global (NASDAQ:PRE) investors has not been profitable (Simply Wall St.)
Aug-08-22 04:45AM	Prenetics Launches Circle Snapshot, Simple At-home Blood Tests Using the World's First Push-Button and Painless Blood Collection Device (PR Newswire)
Jul-16-22 08:03AM	What Kind Of Investors Own Most Of Prenetics Global Limited (NASDAQ:PRE)? (Simply Wall St.)
Jun-08-22 12:56PM	Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong (PR Newswire)
Jun-06-22 09:55AM	Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker "PRE" (PR Newswire)
May-23-22 12:00PM	Video Highlights Covid Testing The English Premier League and Beyond: Join CEOs of Prenetics, Artisan in Fireside Chat (IPO-Edge.com)
08:46AM	New Horizon Health Partners with Prenetics in Hong Kong to Launch ColoClear, a Non-Invasive Stool DNA Test to Detect Colon Cancer (PR Newswire)
May-19-22 12:15PM	Replay Covid Testing The English Premier League and Beyond: Join CEOs of Prenetics, Artisan in Fireside Chat (IPO-Edge.com) -26.41%
May-18-22 06:30PM	Prenetics Rings the Opening Bell and Debuts on Nasdaq (GlobeNewswire)
11:00AM	Loading…
May-17-22 11:00AM	Covid Testing The English Premier League and Beyond : Join CEOs of Prenetics, Artisan in Fireside 10AM ET Thurs (IPO-Edge.com)

Prenetics Global Ltd. is a genomics-driven health sciences company. It operates through the following business units: Early Cancer Detection, Prevention, and Treatment Selection & Monitoring. The Early Cancer Detection detects and analyses fragmentation patterns of plasma DNA, providing a non-invasive epigenetics-based means for the detection of a wide variety of cancers, and is expected to provide an accurate and low-cost method for early cancer detection. The Prevention unit seek to build preventive healthcare platform by utilizing science to empower consumers to achieve their personal health goals. Its in-house developed consumer genetic testing product, Circle DNA, offers one of the most comprehensive DNA tests capitalizing in-house developed testing algorithm. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRE

Prenetics Global Limited

Upgrade your FINVIZ experience